A genetically supported drug repurposing pipeline for diabetes treatment using electronic health records.

The identification of new uses for existing drug therapies has the potential to identify treatments for comorbid conditions that have the added benefit of glycemic control while also providing a rapid, low-cost approach to drug (re)discovery.